Loading
Latest filing published 10 Jul 2026 for BetterLife Pharma Inc., €59k.
No signal scores available.
This profile gathers the share dealings of John LaRocca in BetterLife Pharma Inc. Altogether 2 filings, all relating to 7 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 10 July 2026 with an option exercise (€59k) in BetterLife Pharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations